WO2023037247 - COMPOSITIONS COMPRISING BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING ULCERATIVE COLITIS
National phase entry:
Publication Number
WO/2023/037247
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058383
International Filing Date
06.09.2022
Title **
[English]
COMPOSITIONS COMPRISING BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING ULCERATIVE COLITIS
[French]
COMPOSITIONS COMPRENANT BACILLUS AMYLOLIQUEFACIENS POUR LA PRÉVENTION ET LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE
Applicants **
ARTUGEN THERAPEUTICS LTD.
c/o Byrne Wallace
88, Harcourt Street
Dublin, 2, IE
Inventors
FARQUHAR, Ronald
2 Battery Wharf, Unit #2408
Boston, Massachusetts 02109, US
ACTON, Susan L.
42 Munroe Rd
Lexington, Massachusetts 02421, US
CHESNEL, Laurent
23 rue Droite
82140 Sant Antonin Noble Val, FR
Priority Data
63/241,439
07.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2701 | |
| EPO | Filing, Examination | 20594 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 10110 |

Total: 34570 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
bacteria identified as ART24 to a subject suffering from or at risk for ulcerative colitis.[French]
identifiées comme ART24 à un sujet souffrant de rectocolite hémorragique ou présentant un risque de rectocolite hémorragique.